Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecnoglutide in obesity or overweight
NCT07281937Phase 2Completed
- Start
- Nov 2025
- Primary completion
- Jul 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of ecnoglutide in obesity, Overweight. Started Nov 2025; status: completed.
02
Drugs
ecnoglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07281937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07281937.